Agenda
All agenda times are listed in U.S. Eastern Time. You can check the event start time in your local timezone here.
-
Welcome & introduction
Terry Hyland
Senior Editor, North America, Chemical Watch News & Insight, Enhesa Product Intelligence -
Proposed TSCA amendments: Key provisions under consideration
Kelly Franklin
North America Managing Editor, Chemical Watch News & Insight, Enhesa Product Intelligence - Session one: Understanding today’s regulatory landscape for TSCA reform and PFAS obligations
-
Legal risks and compliance strategies for the PFAS reporting rule
- Legal interpretation of TSCA section 8(a)(7) within the regulatory framework for PFAS reporting obligations.
- Considerations regarding proposed exemptions.
- Compliance and reporting challenges
- Preparing robust submissions and managing legal exposure.
- Enforcement outlook and emerging legal trends.
Lynn L. Bergeson
Managing Partner of Bergeson & Campbell, P.C. (B&C®) and President of The Acta Group, L.L.C. (Acta®), Bergeson & Campbell, USA -
Extended Q&A session
This session examines the EPA’s proposed revisions to PFAS reporting under TSCA, exploring how changes to exemptions, timelines, and data requirements could affect industry, regulators, and public health. Experts will share perspectives on balancing comprehensive information with practical implementation and discuss implications for future chemical reporting frameworks.
Joined by:
-
Refreshment break
- Session two: TSCA risk evaluation reform
-
Legal considerations in TSCA risk evaluation and framework changes
- Legal considerations related to the reconsidered risk evaluation framework rule.
- Key differences between condition-of-use and whole-chemical determinations.
- Potential impact of changes to risk evaluations on risk management approaches.
- Considerations for companies anticipating regulatory shifts and potential remands.
-
Industry insights on TSCA risk evaluation reform and practical implementation
- Operational challenges with evolving risk evaluation criteria.
- Impacts of shifting PPE and exposure assumptions on compliance planning.
- Industry’s role in shaping practical, science-based regulatory outcomes.
- Considerations for enhancing predictability and efficiency in chemical risk review processes.
-
Extended Q&A session
Joined by
Kimberly Wise White
Vice President, Regulatory and Scientific Affairs, American Chemistry Council (ACC) -
Lunch break
- Session three: TSCA risk management approaches and key legal challenges
-
Risk management rule revisions under the Trump administration and signals for future approaches
- Overview of TSCA risk management framework and its evolution.
- Key changes introduced during the trump administration.
- Impacts on industry compliance and regulatory certainty.
- Emerging trends and signals for future risk management strategies.
- Practical steps for businesses to prepare for shifting requirements.
-
TSCA litigation landscape: key legal challenges and regulatory shifts
- Updates on challenges to five EPA risk management rules (methylene chloride, perchloroethylene (PCE), trichloroethylene (TCE), n-methylpyrrolidone (NMP), and asbestos) and implications for industry compliance timelines.
- Reporting obligations and CBI concerns related to the section 8(d) health & safety data rule litigation.
- Legal challenges to PFAS test orders.
- Practical considerations for companies as priorities and deadlines shift.
-
Proactive risk management under TSCA
- Embedding proactive risk management into TSCA compliance and product stewardship programs
- Practical approaches for identifying and mitigating regulatory risks, including strategies for complex chemistries
- Connecting risk management practices with broader sustainability and corporate responsibility goals
- Actionable insights to strengthen industry-wide risk management and compliance frameworks
-
Q&A session
-
Refreshment break
- Session four: Managing new chemical submissions and SNURS in a changing TSCA landscape
-
Regulatory approaches to new chemical reviews
-
From PMN to SNUR: Industry strategies for navigating new chemical reviews
- Internal coordination for preparing robust PMN submissions
- Adapting to EPA’s evolving expectations within operational constraints
- Managing uncertainty in review timelines and risk determinations
- Lessons from recent SNURs and their implications for product development
- Exploring opportunities to enhance transparency and predictability in the review process
-
Q&A session
-
Panel discussion: Downstream stakeholder perspectives on risk, compliance, and innovation
Key topics:
- Impact of TSCA risk evaluations on downstream operations
- Strategies for managing regulatory uncertainty and supply chain disruption
- Innovation in safer chemical alternatives and sustainable product design
- Legal and compliance considerations for downstream actors
Speakers:
-
Refreshment break
- Session five: understanding TSCA fees and anticipating future regulatory developments
-
Key updates on TSCA fees and practical strategies for trade compliance
- TSCA fee rule: status and key exemptions
- Managing fee obligations and disputes
- Trade compliance and IEEPA litigation implications
- Key takeaways for proactive compliance planning
-
Q&A session
-
Panel discussion: TSCA’s future in a changing regulatory landscape
This closing discussion examines potential future directions for TSCA in light of the January 16 draft reform bill, which proposes updates to risk evaluations, new‑chemical review processes, and EPA authorities. Panellists will consider how these proposed changes may influence regulatory implementation, international alignment, innovation, and sustainability planning. The discussion will also address evolving expectations around transparency, data tools, and stakeholder engagement as the policy landscape continues to develop.
-
Close of conference
.jpg)
